DataMeds AI, Inc. (MEDS): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$12.45M

As of 2025-12-31

-$19.50M

As of 2026-06-30

2023-12-31 Shareholders' Equity (USD) 2025-12-31

Period ended	Shareholders' Equity	Change YoY	Source filing
2025-12-31	-$12.45M	n/m	2026-03-20, Balance as of period end
2024-12-31	$6.73M	n/m	2026-03-20, Balance as of period end
2023-12-31	-$2.90M	n/a	2025-03-25, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Shareholders' Equity	Change YoY
DataMeds AI, Inc. (MEDS)	2025-12-31	-$12.45M	n/m
Cosmos Health Inc. (COSM)	2025-12-31	$18.42M	-24.9%
Stemtech Corp (STEK)	2025-12-31	-$6.96M	n/m
HWH International Inc. (ESYN)	2025-12-31	$2.62M	-5.3%
Nu Skin Enterprises, Inc. (NUS)	2025-12-31	$805.24M	+23.6%
Herbalife Ltd. (HLF)	2025-12-31	-$515.10M	n/m
Cardinal Health Inc (CAH)	2026-06-30	-$2.88B	n/m
Cencora, Inc. (COR)	2025-09-30	$1.51B	+133.5%
McKesson Corp (MCK)	2026-03-31	-$1.78B	n/m

Compare MEDS, COSM, STEK, ESYN side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗